Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roscovitine in Cystic Fibrosis (ROSCO-CF)
NCT02649751Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Feb 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seliciclib in cystic fibrosis (CF), sponsored by Centre Hospitalier Universitaire de Brest. Started Feb 2016; status: terminated.
02
Drugs
seliciclib
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02649751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649751.